Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020)
Benitec Biopharma (BNTC) posted Receivables - Other of $21000.0 for Q4 2020, down 64.41% sequentially from $59000.0 in Q2 2020.
Powered by 
Analysis
Benitec Biopharma (BNTC) Receivables - Other (2019 - 2020) Analysis & Trends
Benitec Biopharma has reported Receivables - Other for 2 years, with the latest figure at $21000.0 in Q4 2020.
- Quarterly Receivables - Other changed N/A year-over-year to $21000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $21000.0 (changed N/A YoY) and the FY2020 annual result came in at $59000.0, down 96.89% from the prior year.
- Receivables - Other fell to $21000.0 in Q4 2020 per BNTC's latest filing, from $59000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $1.9 million in Q2 2019 and troughed at $21000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 21,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Jun 30, 2019 | 1.90 Mn |